RLAY
Relay Therapeutics Inc
17.70$
-1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | – | – | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 323.4% | – | 823.5% | – | – | – | – | 9,080.1% | – | 8.6% | 16.8% | – | – | |
| -223.4% | – | -723.5% | – | – | – | 100.0% | -8,980.1% | – | 91.4% | 83.2% | 100.0% | -566.6% | |
| 323.4% | – | 823.5% | – | – | – | 961.2% | 9,438.3% | – | 791.6% | 2,352.1% | 21,852.3% | 2,615.7% | |
| 73.3% | – | 197.9% | – | – | – | 244.0% | 2,010.0% | – | 185.2% | 367.6% | 4,197.4% | 490.4% | |
| 68.6% | – | 179.5% | – | – | – | 1,205.2% | 2,371.0% | – | 957.6% | 2,702.9% | 26,049.7% | 2,432.8% | |
| -291.9% | – | -903.0% | – | – | – | -1,105.2% | -11,351.1% | – | -866.2% | -2,619.7% | -25,949.7% | -2,999.4% | |
| -260.8% | – | -813.3% | – | – | – | -1,003.6% | -10,395.1% | – | -784.1% | -2,443.0% | -23,916.3% | -2,763.6% | |
| -5.4% | – | 13.5% | – | – | – | – | – | – | – | – | – | – | |
| -260.8% | – | -813.3% | – | – | – | -1,003.6% | -10,395.1% | – | -784.1% | -2,443.0% | -23,916.3% | -2,763.6% | |
| -291.3% | – | -907.4% | – | – | – | -987.8% | -10,247.1% | – | -826.4% | -2,426.2% | -23,669.4% | -2,771.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.